Literature DB >> 19022534

"Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.

Joerg C Prinz1, Zsuzsanna Kutasi, Peter Weisenseel, László Pótó, Zita Battyáni, Thomas Ruzicka.   

Abstract

BACKGROUND: Morphea is an inflammatory autoimmune skin sclerosis of unknown etiology. A causative role of Borrelia burgdorferi infection has been controversially discussed, but no conclusive solution has yet been achieved.
OBJECTIVE: Intrigued by 3 young patients with severe Borrelia-associated morphea and high-titer antinuclear antibodies, we retrospectively examined the relationship between Borrelia exposure, serologic autoimmune phenomena and age at disease onset in morphea patients.
METHODS: In 90 morphea patients the presence of Borrelia-specific serum antibodies was correlated to the age at disease onset and the presence and titers of antinuclear antibodies. Patients with active Borrelia infection or high-titer antinuclear antibodies due to systemic sclerosis or lupus erythematosus served as controls.
RESULTS: We observed a statistically highly significant association between morphea, serologic evidence of Borrelia infection, and high-titer antinuclear antibodies when disease onset was in childhood or adolescence. LIMITATIONS: Because pathogenic Borrelia species may vary in different geographic regions the relevance of Borrelia infection in morphea induction may show regional variations.
CONCLUSION: B burgdorferi infection may be relevant for the induction of a distinct autoimmune type of scleroderma; it may be called "Borrelia-associated early onset morphea" and is characterized by the combination of disease onset at younger age, infection with B burgdorferi, and evident autoimmune phenomena as reflected by high-titer antinuclear antibodies. As exemplified by the case reports, it may take a particularly severe course and require treatment of both infection and skin inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022534     DOI: 10.1016/j.jaad.2008.09.023

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Borrelia burgdorferi Infections in the United States.

Authors:  Warren R Heymann; Dana L Ellis
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

2.  [Borrelia infections and skin diseases : The solution to the puzzle].

Authors:  J C Prinz
Journal:  Hautarzt       Date:  2016-07       Impact factor: 0.751

3.  Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score.

Authors:  A Moniuszko; E Gińdzieńska-Sieśkiewicz; S A Pancewicz; P Czupryna; J Zajkowska; S Sierakowski
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

Review 4.  The Immunogenetics of Morphea and Lichen Sclerosus.

Authors:  Pooya Khan Mohammad Beigi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  [Pediatric dermatology. New aspects of bacterial skin infections in children].

Authors:  H Hofmann; C Schnopp
Journal:  Hautarzt       Date:  2009-03       Impact factor: 0.751

Review 6.  Progressive Hemifacial Atrophy and Linear Scleroderma En Coup de Sabre: A Spectrum of the Same Disease?

Authors:  Irina Khamaganova
Journal:  Front Med (Lausanne)       Date:  2018-01-31

Review 7.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

8.  A case of generalized morphea profunda following SARS-CoV-2 infection.

Authors:  Michael R Stephens; Duncan F Moore; Jonathan Dau; Soma Jobbagy; Victor A Neel; Marcy B Bolster; Flavia Fedeles
Journal:  JAAD Case Rep       Date:  2022-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.